Intellia Therapeutics (NTLA) Enterprise Value (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.43% |
| Dec 31, 2025 | 11.97% |
| Sep 30, 2025 | -11.18% |
| Jun 30, 2025 | 8.75% |
| Mar 31, 2025 | 16.25% |
| Dec 31, 2024 | 8.60% |
| Sep 30, 2024 | 4.77% |
| Jun 30, 2024 | 12.67% |
| Mar 31, 2024 | 13.26% |
| Dec 31, 2023 | -6.72% |
| Sep 30, 2023 | 5.87% |
| Jun 30, 2023 | 2.73% |
| Mar 31, 2023 | 21.72% |
| Dec 31, 2022 | -44.00% |
| Sep 30, 2022 | 5.27% |
| Jun 30, 2022 | -2.22% |
| Mar 31, 2022 | -13.92% |
| Dec 31, 2021 | 5.95% |
| Sep 30, 2021 | -50.90% |
| Jun 30, 2021 | 9.42% |
| Mar 31, 2021 | 2.23% |
| Dec 31, 2020 | -46.43% |
| Sep 30, 2020 | 6.61% |
| Jun 30, 2020 | -74.54% |
| Mar 31, 2020 | 10.53% |
| Dec 31, 2019 | 2.17% |
| Sep 30, 2019 | -5.47% |
| Jun 30, 2019 | -475.62% |
| Mar 31, 2019 | 85.00% |
| Dec 31, 2018 | -7.10% |
| Sep 30, 2018 | 4.02% |
| Jun 30, 2018 | 6.79% |
| Mar 31, 2018 | 3.79% |
| Dec 31, 2017 | -53.28% |
| Sep 30, 2017 | 7.79% |
| Jun 30, 2017 | 6.41% |
| Mar 31, 2017 | 5.68% |
| Dec 31, 2016 | 6.04% |
| Sep 30, 2016 | 3.35% |
| Jun 30, 2016 | -368.42% |
| Mar 31, 2016 | 15.33% |
| Dec 31, 2015 | 8.23% |
| Sep 30, 2015 | -317.97% |
| Jun 30, 2015 | -6.96% |